Earnings calendar

Jazz Pharmaceuticals plc (JAZZ) earnings: date, estimates, results and stock reactions

Over the last 12 reports the stock moved 7.1% on average (either way), rising 7 times and falling 5. EPS beat estimates 7 of 12 times; revenue 7 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q3 FY20262026-11-02-3.88-4.03+3.7%1.24B1.21B+6.4%
Q2 FY20262026-08-035.716.18-7.6%1.21B1.11B+3.5%
Q1 FY20262026-05-056.344.64+36.6%1.07B978.7M+9.9%
Q4 FY20252026-02-246.646.52+1.8%1.20B1.17B+13.6%
Q3 FY20252025-11-058.135.95+36.6%1.13B1.11B-2.7%
Q2 FY20252025-08-05-8.25-6.12-34.8%1.05B1.05B-8.8%
Q1 FY20252025-05-061.684.51-62.7%897.8M1.06B-14.2%
Q4 FY20242025-02-256.605.83+13.2%1.09B985.0M+5.5%

JAZZ stock report · Earnings calendar